EBS
Emergent BioSolutions Exceeds Expectations with Strong Q2 2026 Results
Emergent BioSolutions Inc. recently reported its second-quarter 2026 financial results, exceeding both internal and consensus expectations. The company's strong performance was highlighted during a conference call on August 5th, 2026, where President and CEO Joe Papa shared updates on the company's multi-year transformation plan and business